



Expanding one-pot cell-free protein synthesis and immobilization for on-
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Fabrication of protein-based biomaterials is an arduous and time-consuming procedure with multiple 
steps. In this work, we describe a portable tool-kit that integrates both cell-free protein synthesis 
(CFPS) and protein immobilization in one-pot, just by mixing DNA, solid materials and a CFPS system. 
We construct a modular set of plasmids that fuse the N-terminus of superfolded Green Fluorescent 
Protein (sGFP) with different peptide-tags (poly-(6X)Cys, poly-(6X)His and poly-(6X)Lys), which drive 
the immobilization of the protein on the tailored material (agarose beads with different functionalities, 
gold nanorods and silica nanoparticles). This system also enables the incorporation of azide-based 
amino acids into the nascent protein for its selective immoblization through copper-free click reactions. 
Finally, this technology has been expanded to the synthesis and immobilization of enzymes and 
antibody-binding proteins for the fabrication of functional biomaterials. This synthetic biological 




































The utilization of biomaterials for biomedical purposes is exponentially growing in the last decade.
1
 







 and contrast agents for molecular imaging.
5
 In terms of 
biological activity, proteins (antibodies, cytokines receptors, ligands, enzymes, etc.) are among the 
most interesting biomolecules to functionalize the solid materials.
6
 Generally, the manufacturing of 
protein-based biomaterials includes: 1) synthesis of suitable materials for certain application, 2) 
expression and purification of the protein and 3) immobilization of the protein on the solid material.
7
 
This multi-step workflow is designed for bulk production of biomaterials in sophisticated and 
centralized production facilities, but it fails when the manufactured products need to be deployed at 
the point-of-care or are economically non-viable at small scales like orphan drugs.
8
  
The major restriction for rapid and efficient protein-based biomaterial manufacturing relies on the 
stability of the biological element. The production and storage of proteins is tied to its labile nature, 
which limits their delivery to remote areas where the cold chain cannot be assured. Another hurdle for 
the rapid manufacturing of this type of biomaterials is the biosafety regulations when proteins are 
produced in living organisms, which require specific skills and specialized facilities, limiting the 
operation in low-resource areas. Finally, once the protein is conjugated to the material, the greatest 
challenge is preserving the biological function of the biomaterials during storage and distribution.  
On-demand synthesis of protein-functionalized biomaterials at the point of care requires the rapid 
synthesis and immobilization of the protein in one-pot. However, the multi-pot in vivo protein synthesis 
and purification are time-consuming and hardly miniaturizable. Alternatively, cell-free protein synthesis 
(CFPS) is a promising technology to readily synthesize well-folded proteins
9
 on-demand since crude 
extract have been successfully engineered to maximize the productivity and sustain the energy levels 
that assures competitive protein yields compared to in vivo systems.
10,11
 Hence, incorporating CFPS to 
biomaterial manufacturing allows the simultaneous protein synthesis and immobilization in the same 
test tube. Now, the fabrication system only relies on the stability of the materials and the freeze-dried 






To this aim, the immobilization chemistry must be orthogonal to the protein synthesis, avoid 
unspecific interactions between the protein synthesis machinery and the solid material, and correctly 
orient the protein to guarantee the functionality of the resulting biomaterial. A previous work showed a 
CFPS-i of membrane proteins tagged with GFP at their C-terminus and immobilized on PVDF 
membranes through hydrophobic interactions.
15
 Unfortunately, this kind of hydrophobic interaction is 
not very selective to expand this technique for new applications.  Protein tagging with polypeptide or 
protein domains is the most widespread strategy to purify proteins for biochemical and structural 
studies. Furthermore, the tag serves to control the orientation of protein when immobilized on solid 
materials.
16,17







 and iron oxide
21
 through coordination and covalent 
bonds, silica particles
22
 through ionic interactions, biopolymeric particles such as agarose beads
23
 
through multivalent interactions based on hydrogen and Van der Waals bonds, and even oil-droplets
24
 
through hydrophobic interactions.  
 
Figure 1. CFPS-i reaction with a set of plasmids encoding sGFP gene. (A) One-pot CFPS-i 
process for the manufacturing of biomaterials. (B) Modular plasmid set for the biomaterials 
manufacturing. Plasmid architecture shows the restriction enzymes needed to modularly exchange the 
target protein and the tag. 
 
In several pioneering works, CFPS was utilized for the fabrication of self-assembling protein 




 and other protein array-based approaches.
15, 27, 28 
This concept was further extended to the protein synthesis and selective immobilization by using 
Histag.
29-31
 These systems have been successfully applied for drug discovery and protein 
engineering.
14,30






span membrane proteins on oil drops, as therapeutic biomaterial for killing cultured cancer cells.
32
 This 
one-pot concept may improve the on-demand fabrication of biomaterials, overall in the prototyping 
phase of the manufacturing.   
Here, we expand the synthetic biological platform coupling cell-free synthesis and immobilization 
of proteins (CFPS-i) in a single test tube for manufacturing biomaterials (Figure 1A). This portable 
system may work at the point-of-care just adding DNA templates, CFPS systems and on-demand 
materials. The toolbox of polypeptide tags and their different immobilization chemistries open a wide 
range of possibilities for the on-demand fabrication of biomaterials in one-pot. Moreover, the co-
expression and co-immobilization of several proteins may improve the scope of this approach. Finally, 
we extend this technological platform to the production of biomaterials based on enzymes and 
antibodies demonstrating the biological functionality of the synthesized and immobilized proteins. 
 
RESULTS AND DISCUSSION 
Construction of a plasmid set for CFPS-i: a versatile and modular genetic system  
We fabricated a set of plasmids that enconde superfolded green fluorescent protein (sGFP) 
fused to the N-terminus with different polypeptide tags. In this construction, both the sGFP and the tag 
sequences can be easily exchanged by others just by enzymatic digestion (Figure 1B and Figure S1A). 
Hence, the modular genetic toolbox design enables to easily fuse any target protein with any 
polypeptide tag. To proof the modularity of this architecture, we constructed three plasmids expressing 
sGFP harboring at its N-terminus poly-(6x)His (His-sGFP), poly-(6x)Lys (Lys-sGFP) or poly-(6x)Cys 
(Cys-sGFP) peptides that selectiviely immobilize the protein on different solid materials activated with 
metal chelates, negative charges or disulfide groups, respectively (Figure 1B). After transformation in 
E.coli, all these plasmids similarly expressed in vivo the sGFP tagged with the different tags (Figure 
S2) accordingly to previous results that demostrate that sGFP expression remains unaltered 
regardless the position (N- or C-terminus) and the presence of the tag.
33
 Nevertheless, the in vitro 
expresion of the untagged sGFP was significatly more efficient than the expresion of the tagged 
variants which presented different expression levels between them (Figure S3). The in vitro expression 
of Lys-sGFP was lower than His-sGFP, and significantly lower than Cys-sGFP. These data correlate 
with the amino acids content in the sGFP primary sequence; 20 lysines, 11 Histidines and 2 cysteines, 
which suggests that the amino acid or tRNAs pools may be the limiting factor to achieve high protein 




Cell-free synthesis and immobilization of His-sGFP in one-pot 
To demostrate that protein synthesis and immobilization can occur orthogonally and 
simultaneously, we synthesized His-sGFP with commercially available S30 cell-free extract from E. 
coli in presence of porous agarose particles activated with cobalt-chelates (AG-Co). Expectedly, 
protein synthesis was not observed when empty pET28b was used as negative control. On the 
contrary, when the CFPS system was incubated with the plasmid encoding the untagged sGFP and 
the beads, the fluorescence appears and remaims in the reaction bulk without selectively colonizing 
the beads (data not shown). Finally, only when the plasmid expressing the His-sGFP and AG-Co were 
incubated with the cell-free extract, we observed the selective confinament of the fluorescence in the 
bead surface. Under this conditions, we were able to load up to 2.8  0.2 mg of protein per gram of 
carrier after 12 hours (see METHODS section for more information). These experimental evidences 
demostrate the in vitro synthesis and concurrent selective immobilization of the protein but only when 
the protein tag/bead pair is properly selected. To better understand the dynamics of this two-step/one-
pot process, we performed the synthesis and immobilization of His-sGFP immobilized on AG-Co by 
measuring sGFP fluorescence along the time (Figure 2). 
The on-line monitoring of the process reveals that sGFP gene under the control of T7 
promoter is transcribed and translated producing a His-tagged nascent protein that is subsequently 
immobilized on the AG-Co. As we can see from the time-course images, fluorescence is barely 
accumulated in the bulk during the entire process (Figure 2A, Movie S1). This fact suggests that the 
immobilization rate is higher than the synthesis rate, converting the latter into the rate-limiting step. 
Despite CFPS reactions in solution normally reach the maximum protein yields in 2-4 hours,
34, 35
 the 
accumulation of the nascent proteins inside the porous beads continued for more than 12 hours and 
never reached a plateau (Figure 2A). Furthermore, we can observe that larger beads are more 
efficient in recruiting the nascent proteins due to their higher surface (Figure 2A). Finally, the on-line 
monitoring of the CFPS-i process also reveals a uniform distribution of His-sGFP within the 
microstructure of the beads (Figure 2B). A similar uniform distribution was found in a similar set-up but 
using agarose beads activated with nickel-chelates.
14
 Once the CFPS-i system was demonstrated to 
be functional, we re-used the cell extracts by separating the loaded beads and incubated the cell 
extracts with fresh empty beads, cofactors and reagents to the cell-free solution. Unfortunately, the 
protein synthesis yield diminished 96.0% after the second use (Figure S5). Finally, we freeze-dried the 






We pleasantly achieved the same protein synthesis yield after 12-hour reaction with both, freeze-dried 
and no freeze-dried cell extracts, although the synthesis rate was 2.63 times slower using the freeze-
dried cell extracts than the commercial solution (Figure S6). 
Figure 2. On-line monitoring CFPS-i by fluorescence microscopy. (A) sGFP fluorescence inside 
the beads and in the background (the reaction media outside the beads) along the time. Beads were 
grouped according to their size. The mean fluorescence value at each time point corresponds to the 
average fluorescence of 3 beads. (B) Fluorescence microscopy images overlaying brightfield and 
sGFP signals before (left) and after (right) CFPS-i reaction was completed.  
In order to demonstrate that all His-sGFP was immobilized on AG-Co at 2.8 mg/g of loading, 
we also performed an immobilization time-course of His-sGFP (in vivo expressed) (Figure S7). Under 
these conditions, the immobilization was monitor by measuring the sGFP fluorescence inside and 
outside the AG-Co by using a multi-plate fluorimeter, a method with lower limit of detection. After 12 
hours of immobilization reaction, we detected more than 96% of sGFP on AG-Co, meanwhile less than 
t = 0 h t = 12 h
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4% of the initial solution of in vivo expressed sGFP was detected outside beads. These results sustain 
a high efficiency of the CFPS-i platform, at least for 2.8 mg/g of protein loading. 
 
Synthesis on-demand of different biomaterials functionalized with sGFP tagged with different 
tags 
First of all, we tested the high selectivity of CFPS-i producing Cys-sGFP in presence of two 
different materials, AG-Co and methacrylate beads activated with epoxide groups (Pu-E). Nascent 
Cys-sGFP was exclusively immobilized on Pu-E (Figure 3), as result of the specific interaction 
between the thiol groups of the Cys-tag and the epoxide groups of the carrier. 
 
 
Figure 3. CFPS-i of Cys-sGFP in presence of AG-Co and Pu-E. (A) Scheme of the selective 
binding between the Cys-GFP and Pu-E (black) in presence of AG-Co (pink). (B) Fluorescence 
microscopy images overlaying brightfield and sGFP signals before and after the CFPS-i reaction was 
accomplished.  
 
To expand the scope of the CFPS-i methodology, we coupled the synthesis of Cys-sGFP and 
Lys-sGFP to their selective immobilization on gold nanorods (AuNRs) and silica nanoparticles 
(SiO2NPs), respectively (Figure 4 and Figure S8). Cys-sGFP was efficiently immobilized on the 
AuNRs due to the formation of thiol-gold covalent bonds (Figure 4A); this chemistry has been 
extensively exploited in the biofunctionalization of gold-based nanomaterials.
36
 Likewise, Lys-sGFP 
was selectively and stably absorbed on SiO2NPs through the ionic interaction between the positive 
charges of the -NH2 group of the Lysine-tag and the negatively charged surface of these 
nanoparticles (Figure 4B), accordingly to the results obtained with other basic domains and tags fused 
to the protein of interest.
22
  






Figure 4. CFPS-i of sGFP onto on-demand materials by selective polypeptide-tags. (A) Cys-
sGFP. (B) Lys-sGFP. From left to right, scheme of the selective binding between the polypeptide-
tagged sGFP and the nanoparticle, fluorescence microscopy images overlaying brightfield and sGFP 
signals for the control reaction with untagged sGFP (-Cystag / -Lystag) and for the reaction with 
polypeptide-tagged sGFP (+Cystag / +Lystag). 
 
In both cases, the untagged sGFP was synthesized but not immobilized on both nanoparticles (Figure 
4). The interaction between the Lys-tag and the silica surface is very selective, although we observed 
some unspecific interactions between proteins from the CFPS machinery and the SiO2NPs (Figure S9). 
In addition, we also demonstrated that free amino acids contained in the S30 premix plus were not 
competing with the poly-peptide sGFP for the reactive groups, achieving similar protein immobilization 
yields with and without free amino acids in the bulk. We observed similar protein immobilization 
kinetics in both cases (Figure S4). 
CFPS-i reaction was also carried out by drop-casting the corresponding plasmid and cell-free 
protein synthesis machinery on the top of glass slides, letting the reaction mixture react for 12 hours 
and then intensively washing the glass surface with buffered solution. Herein, the protein synthesis 
was successfully accomplished since fluorescence was detected in drops containing either tagged or 
untagged proteins after the reaction time (Figure 5 and Figure S10). After the washing step, the drops 
containing the plasmid encoding Lys-sGFP displayed fluorescence spots at the glass, while no 
fluorescence was detected in those drops that in vitro expressed the untagged protein, since it was 
removed from the surface during the washing step (Figure 5). These experimental data corroborate 











other solid architectures. This technology skips the chemical functionalization steps of glass slides 
required for the conventional proceedings to prepare protein-based microarrays.
37
   
 
Figure 5. CFPS-i of Lys-sGFP onto glass slides. System expressing (A) Lys-sGFP and (B) 
untagged sGFP 
Incorporation of non-natural amino acids through CFPS to enable bio-orthogonal 
immobilization mediated by copper-free click chemistry 
 In order to go beyond the chemistry offered by the nature, we also expanded the CFPS-i to 
copper-free click chemistry reactions by incorporating non-natural amino acids harboring azide groups 
into the nascent proteins and functionalizing materials with cyclooctyne groups. To this aim, we firstly 
activated agarose beads with cyclooctyne groups through a new surface chemistry protocol starting 
from commercially available agarose beads activated with cyanogens bromide (Figure S11). Figure 6 
shows that protein synthesis fails and fluorescence can be detected neither in the bulk nor inside the 
beads as expected when neither methionine nor L-AHA (L-azidohomoalanine) is included in the amino 
acid mixture. Furthermore, when the protein is synthesized with methionine, the protein is produced 
but immobilization on cyclooctyne-activated agarose beads does not occur, remaining the nascent 
protein in the reaction bulk. Likewise, when the protein is synthesized with L-AHA but incubated with 
agarose beads activated with hydroxyl groups instead of cyclooctyne ones, sGFP fluorescence is only 










These experimental data demonstrate that the synthesis and copper-free click-immobilization 
of sGFP is only possible when azide side chains are displayed in the protein surface and the agarose 
surface is activated with cyclooctyne groups (Figure 6). According to the sGFP X-ray structure (PDB: 
2B3P), L-AHA can be introduced at position 1, 78, 88 and 216 of the protein primary sequence. 
Positions 1, 78 and 88 cluster at the bottom part of the β-barrel where N- and C-terminus are located, 
while position 216 is located at the hollow of the barrel facing the chromophore (Figure S12).   
 
Figure 6. CFPS-i of sGFP incorporating non-natural amino acids by copper-free click chemistry. 
Fluorescence microscopy imaging overlaying brightfield and sGFP signals after the CFPS-i was 
completed. The images show the reaction in presence of each amino acid: Met (methionine) or AHA 
(L-azidohomoalanine) and the agarose beads activated or not with cyclooctyne (oct) groups. 
 
Although the incorporation of non-natural amino acids for protein-based biomaterials 
manufacturing has been already described,
38-40 
here we have coupled the protein synthesis with a 
cyclooctyne/azide click-immobilization in one-pot concurrent process, unlike two-pot conventional 
methods where firstly azide- or alkyne-amino acids are incorporated either in vivo or in vitro into the 
protein. Then, the modified protein is purified and incubated with solid particles functionalized either 




 For a more precise site-selective immobilization, the CFPS-i 
developed here can be coupled to cell-free AMBER system, by using specific tRNAs to insert non-
natural amino acids in unique positions.
43
 Therefore, we demonstrate that the cooper-free click-
immobilization based on cyclooctyne/azide pairs is compatible with the protein synthesis according to 
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In vitro synthesis and selective co-immobilization of two proteins fused to different tags on the 
same carrier 
The co-immobilization of different enzymes on the same carrier is a frequent strategy to 
assemble complex biological machineries like multi-enzyme systems.
45,46
 In order to gain selectivity 
during the co-immobilization protocol, we have applied the toolbox of polypeptide-tags herein 
developed to simultaneously synthesize two different proteins and selectively co-immobilize them on 
the same carrier through two different immobilization chemistries. As a proof of concept, we in vitro 
synthesized Cys-sGFP and an alcohol dehydrogenase from Bacillus stearothermophilus tagged with 6 
histidines at its N-terminus (His-ADHBs). In order to evaluate orthogonality of our toolbox for CFPS-i, 
we prepared a new agarose-based heterofunctional carrier activated with both cobalt-chelates and 
disulfide groups (Figure S13). This new surface theoretically allows the co-immobilization of Cys- and 
His-tagged proteins simultaneously through two different immobilization chemistries based on 
reversible covalent disulfide and reversible metal coordination bonds, respectively (Figure 7A). This 
concept was demonstrated by incubating the heterofunctional carrier with the corresponding DNA 
plasmids and the cell-free extract for the one-pot co-expression and co-immobilization of His-ADHBs 
and Cys-sGFP. As a control reaction, we also expressed only Cys-sGFP in presence of the 
heterofunctional carrier.  
 
 
Figure 7. Co-expression and co-immobilization of two different proteins by two different 
chemistries. (A) Scheme of the immobilization of Cys-sGFP (up) and the co-immobilization of Cys-




(B) Overlay of brightfield and sGFP signals imaging. (C) Relative NADH consumption catalyzed by 
His-ADHBs and Cys-sGFP co-immobilized (white circles) and the control reaction with empty beads 
(black squares). 
 
As read out to demonstrate the co-expression and co-immobilization of these two proteins, we 
visualized the fluorescence of Cys-sGFP by fluorescence microscopy (Figure 7B) and 
spectrophotometrically measured the activity of His-ADHBs attached to the carrier after washing steps 
to remove the protein synthesis machinery (Figure 7C). These experiments evidence that Cys-sGFP 
and His-ADHBs are co-expressed and co-immobilized on the same beads. However when we 
performed the CFPS-i using only the plasmid that encodes Cys-sGFP, the fluorescence intensity per 
bead was 4.22-times higher than when using the two different plasmids (Figure S14). This dissimilarity 
points out a possible competition between the two transcribed mRNA for the ribosomal machinery that 
may diminish the specific final yields for both Cys-sGFP and His-ADHBs. Karim and Jewett observed 
a similar decreasing effect on the protein expression levels when they tried the cell-free co-expression 
of several enzymes.
47 
According to Park et al., mRNA species must compete for a finite pool of 
ribosomes and aminoacyl-tRNAs when CFPS reaction mixtures are primed with several DNA 
templates, leading to unequal expression level of different proteins. Indeed, sGFP fluorescence was 
reported to be inversely proportional to translation rates of the co-expressed genes.
48 
Beside the 
fluorescence of the immobilized Cys-sGFP that reveals its proper folding and structurally innocuous 
immobilization, His-ADHBs in vitro synthesized and immobilized was catalytically active after CFPS-i 
(Figure 7C). The multimeric nature of this enzyme was not a hurdle for its successful expression and 
in situ immobilization by using the CFPS-i system, validating the feasibility of our technology for 
fabrication of solid platforms harboring more complex biological systems. Additionally, the 
orthogonality and selectivity of these two immobilization chemistries was demonstrated by selective 
elution of His-ADHBs in presence of EDTA, while the Cys-sGFP remained attached to the surface. 
Likewise, the Cys-sGFP was eluted to the solution by using thiolated compounds (Figure S15).  
 
Two-pot fabrication of immunoconjugates by CFPS-i 
The demonstrated plasticity of our methodology encouraged us to manufacture biomaterials 
for inmunosensing assays. In order to conceive a wide-ranging device, we decided to synthesize and 
immobilize protein A (ProA) by using CFPS-i. Materials functionalized with ProA mean a universal 
platform for binding to the Fc region of any Immunoglobulin G (IgG).
49




reported plasmid that encodes ProA tagged with 6xHis-tag (His-ProA) at its N-terminus under the 
control of the T7 promoter.
50
 In a first attempt, we incubated the plasmid DNA, the cell-free extract, the 
cobalt-activated beads and an IgG chemically conjugated with both rhodamine and alkaline 
phosphatase (AP-IgG-Rh) in one test tube to perform the CFPS-i of His-ProA and the subsequent IgG 
capture in one-pot. Unfortunately, the antibody was not able to be bound to the beads functionalized 
with the nascent ProA under the protein synthesis and immobilization conditions. In the light of this 
unsatisfactory result, we firstly expressed and immobilized His-ProA on cobalt-activated agarose 
beads in one pot (Figure 8A) and finally AP-IgG-Rh was incubated with those beads in a second pot 
(Figure 8B). The fluorescence and the enzyme activity conjugated to the IgG enabled to trace the 
antibody capture reaction. When AP-IgG-Rh was incubated with AG-Co lacking the His-ProA, we 
neither visualize fluorescence inside the beads nor detect enzyme activity after sample washing 
(Figure S16). 
As a result, the fluorescence of the AP-IgG-Rh was uniformly distributed on the His-ProA 
agarose beads, pointing an optimal antibody density for antigen recognition as previously reported for 
the direct immobilization of IgG on porous agarose particles.
16, 51
 However, the labeled antibody was 
not quantitatively captured by the beads functionalized with His-ProA; 43% of the offered antibody was 
immobilized (Figure S16). Hence, we demonstrate that His-ProA can be synthesized and immobilized 
in one-pot retaining its capacity to selectively capture conjugated IgGs, giving rise a two-step process 
for the fabrication of immobilized immunoconjugates. These results suggest that the protein synthesis 
conditions inhibit the affinity interaction between the Fc region of the antibody and the His-ProA. This 
strategy may contribute to developing innovative immunological platforms not only for manufacturing 
tailor-made biosensors and pull-down systems
52







CFPS-i reaction Incubation with IgG
t = 0 h t = 12 h
A B
50 µm 50 µm50 µm
Figure 8. Two-pot synthesis of immunoconjugates by using CFPS-i. (A) Scheme and 
fluorescence microscopy imaging of CFPS-i of His-ProA (brown) on AG-Co (pink). (B) Scheme and 
fluorescence microscopy imaging of IgGs (blue) labeled with rhodamine (orange star) and captured by 




In summary, we have coordinated protein synthesis and immobilization in one-pot by 
developing a set of plasmids ready to use with suspensions of cell-free protein synthesis and solid 
materials to fabricate on-demand protein-based biomaterials. This technology is fully portable since it 
requires neither specialized equipments nor infrastructures. Here, we demonstrate that the in vitro 
synthesis of protein is orthogonal to a variety of solid materials as carriers and a diversity of 
immobilization chemistries that attach the nascent proteins to the carriers (see a summary in Table 1). 
We also exploited this system to produce multimeric proteins and biological conjugates (IgG-proteinA). 
However the optimal synthesis of larger proteins with quaternary structure and the in situ formation of 
biological complexes through specific protein-protein interactions will be some of the most important 
challenges this technology will must face in the near future.  
The examples reported in this work encourage us to expand the CFPS-i technology to 
continuous-flow manufacturing of protein-based biomaterials as already proposed for the synthesis of 
active pharmaceutical ingredients
53, 54
 and for bionanotechnology solutions. For instance, the 
integration of the CFPS-i platform into automated and miniaturized systems under GMP (good 
manufacture practices) conditions will undoubtedly boost the on-demand manufacturing of protein-
based biomaterials at the point-of-care, and the discovery of new biomaterials by prototyping their 




of the clues to make individualized drugs manufacturing a reality.
55
 They suggest that evolving from 
large scale pharmaceutical production to low scale and automated models, one can address the 
manufacturing of drugs for ultra-orphan and highly-rare diseases in a cost-efficient manner. Hence, we 
foresee our technology to play an important role in the personalized medicine when nanotechnology 
definitively bursts into clinical treatments.   
 
Table 1. Description of synthesized biomaterials. 
Tagged protein  Binding material Binding interaction Elution reagent 
His-sGFP 
AG-Co 
 (Cobalt chelates activated agarose) 
Metal coordination bond Imidazol 
His-ADHBs 
Cobalt chelates and disulfide groups 
activated agarose  
Metal coordination bond Imidazol 
His-ProA 
AG-Co  
(Cobalt chelates activated agarose) 
Metal coordination bond Imidazol 
Cys-sGFP 
Pu-E Covalent - 
Au-NRs Covalent - 
Cobalt chelates and disulfide groups 
activated agarose 
Thiol exchange DTT 
Lys-sGFP 
SiO2NPs Ion exchange Sodium chloride 
Glass slide Ion exchange Sodium chloride 
sGFP containing 
AHA 







Reagents and Materials: S30/T7 High yield protein expression system was supplied by Promega 
Corporation (Fitchburg, WI). Rhodamine B Isothiocyanate, Dibenzocyclooctyne-amine, Anti-Rabbit IgG 
(whole molecule)–Alkaline Phosphatase antibody produced in goat, 4-Nitrophenyl phosphate disodium 
salt hexahydrate (pNPP), 5,5′-Dithiobis(2-nitrobenzoic acid), 1,4-Dithiothreitol (DTT), 
Ethylenediaminetetraacetic acid (EDTA), Cyanogen bromide-activated Sepharose 4B, L-Lysine, L-
Cysteine, L-Histidine and primers were acquired from Sigma-Aldrich (St. Louis, IL). Click-it AHA (L-
azidohomoalanine) was supplied by Thermo Fisher Scientific. 6 channel μ-Slide VI 
0.4
 was purchased 
from ibidi (Planegg, Germany) and epoxy methacrylate beads Lifetech ECR8204 (Pu-E) were kindly 
donated by Purolite Ltd (Llantrisant, UK). The Colloidal nanofabrication platform from CIC-
BiomaGUNE synthesized the AuNR and SiO2NP (See supporting information, section 7). Agarose-




disulfide and cobalt-chelates groups were fabricated using plain agarose beads purchased from ABT 
technologies (Madrid, Spain) (See supporting information, section 1). 
Genetic engineering a toolbox of plasmids: Plasmid pET-28b(+) (Novagen) was used for cloning 
and protein expression. The genetic construction His-sGFP_pET28b was developed in a previous 
work.
56
 We designed eight primers (Table S1) for cloning Cys-sGFP, Lys-sGFP and untagged sGFP 
using as template the plasmid His-sGFP_pET28b. Firstly, we amplified by PCR the sequence 
upstream of the sGFP gene using primers 3 and 8 for the construction of Cys-sGFP_pET28b. 
Secondly, the downstream sequence was amplified with primers 7 and 4. Finally, we performed an 
overlapping PCR by using primers 3 and 4, and the previous PCR products as megaprimers. The 
pET-28b vector was digested with the restriction enzymes NcoI and XhoI. Afterwards, the overlapping 
PCR product and the digested vector were purified and ligated by homologous recombination in E.coli 
strain DH10β (laboratory stock). The same procedure was carried out for the genetic construction of 
Lys-sGFP_pET28b with primers 3 and 6; 5 and 4; 3 and 4. Cloning of sGFP_pET28b was 
accomplished with primers 2 and 1 for the amplification of untagged-sGFP sequence. The resulting 
PCR product and the vector were further digested with NcoI and XhoI. After the dephosphorilation and 
purification of the DNA fragments, we ligated the DNA fragments and transformed them in BL21-Gold 
(DE3). All molecular biology protocols were performed using standard methods.
57
  
In vitro cell-free protein synthesis and immobilization: The CFPS system was composed of 40% of 
S30 Premix Plus and 30% of T7/S30 extracts. In case of click reactions, we mixed 40% of S30 Premix 
without amino acids, 10% of amino acid mixture minus methionine, 10% of amino acid (methionine or 
L-AHA) and 30% of T7/S30 extracts. We added 1 μg of DNA template and 1 mg of carriers to the cell 
lysate-based expression system at final volume of 50 μL, unless otherwise specified. The reactions 
were performed at 37 ºC and 1200 rpm for 12 hours in an Eppendorf Thermomixer R. 1mM CTAB was 
added to CFPS-i reactions with Pu-E and AuNR to avoid unspecific hydrophobic interactions and 
particle aggregation, respectively. Once the CFPS was finished, protein-based biomaterials were 
easily purified from the reaction mixture by rapid and low-cost filtration using mini Bio-spin 
chromatography columns. 
Determination of His-sGFP loading on AG-Co: Solutions of in vivo expressed sGFP were 
incubated with AG-Co for 1 hour to achieve protein loadings from 0.5 mg/g to 5 mg/g. The sGFP 
fluorescence from 10 beads of each loading was analyzed by ZEN 2012. The results were plotted in a 




Enzymatic activity assay: The enzymatic assays were carried out in a Varioskan
TM
 Flash 
Multimode Reader (Thermo Scientific) using 96-well plates. For both soluble and immobilized enzyme 
the activity was measured under orbital shaking integrated into the reader. See supporting information 
section 2 for more details. 
Fluorescence microscopy imaging: After the CFPS-i was completed, 10 µL of the reaction mixture 
were placed on a channel of 6 channel μ-Slide VI 
0.4
. The brightfield transmission and fluorescence 
(λexc: 470 nm, λem: 500-550 nm) images were obtained with a Cell Observer (Axio Observer, Zeiss) 
microscope. In order to better visualize AuNR and SiO2NP, the samples were 3 times washed with 25 
mM sodium phosphate buffer (pH 7) before their visualization. Images were processed with ZEN 2012 
(Zeiss) and FIJI/ImageJ softwares. 
 
ABBREVIATIONS 
AG-Co Agarose microbeads activated with Cobalt chelates groups 
AP-IgG-Rh Inmunoglobulin G chemically conjugated with both rhodamine and alkaline phosphatase  
AuNRs Gold nanorods  
CFPS Cell-free protein synthesis 
CFPS-i Cell-free protein synthesis and immobilization 
Cys-sGFP sGFP tagged with poly-(6x)Cys 
His-ADHBs  Alcohol dehydrogenase from Bacillus stearothermophilus tagged with poly-(6X)His 
His-ProA Protein A tagged with poly-(6X)His 
His-sGFP sGFP tagged with poly-(6X)His 
L-AHA  L-azidohomoalanine 
Lys-sGFP sGFP tagged with poly-(6x)Lys 
Pu-E Methacrylate microbeads activated with epoxide groups  
sGFP superfolded Green Fluorescent Protein 
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